Salt Lake City’s Recursion, a leading clinical stage biotech company decoding biology to industrialize drug discovery, today celebrated the opening of its 28,000 square foot Toronto site, which will serve as the headquarters for Recursion Canada.
The new site represents Recursion’s significant growth in Canada and its continued investment in the local economy. In total, Recursion currently employs approximately 100 highly skilled employees in Canada, and the Toronto site is Recursion’s largest site outside of its global headquarters in Utah.
“We are thrilled to officially open Recursion’s Toronto office and expand our presence in Canada,” said Chris Gibson, Ph.D., Co-Founder and CEO of Recursion.
“Toronto has long been recognized as a center for cutting-edge technology, and our investment in this vibrant city reflects our confidence in the immense potential of the burgeoning TechBio sector to drive economic growth. We are excited to collaborate with top talent in the region and accelerate the discovery of new medicines that will radically improve patients’ lives.”
The opening of Recursion’s Toronto site closely follows the company’s recent acquisitions of two leaders in AI-enabled drug discovery: Cyclica, based in Toronto, and Valence, based in Montréal.
Both companies have developed cutting-edge machine learning methods and models in the digital chemistry space, which are highly complementary to Recursion’s capabilities, creating one of the most complete, technology-enabled drug discovery solutions in the biopharma industry.
In line with the company’s commitment to sustainability, the new building is designed to meet the requirements of the Toronto Green Standard. This includes intelligent energy, stormwater and waste management systems, features to encourage sustainable commuting options, and a green roof.
“The expansion of this company creates a ripple effect throughout our ecosystem, igniting collaboration with research institutions, universities, and startups in the Toronto Region,” said Stephen Lund, CEO of Toronto Global.
“At Toronto Global, our team has always been advocating for more infrastructure for life sciences companies looking to scale and innovate in the Toronto Region. Thank you to Recursion for working so closely with our Investment Attraction team during this incredible journey and we look forward to supporting your future success.”